Protas

#Clinical trial #GSK #Protas

GSK signs agreement to streamline clinical trials 

GSK has announced an agreement with Protas to streamline clinical trials of vaccines and therapeutics.  The three-year agreement sets out to build on an existing two-year relationship and will broaden the scope of work across numerous projects. This includes Phase II and III trials within GSK’s respiratory,… Read More

#News

Clinical trial
#Clinical trial design #Clinical trials #Collaboration #Duke Clinical Research Institute #Partnership #Protas

Research organisations partner to transform clinical trials

The Duke Clinical Research Institute (DCRI) and Protas, led by Oxford University clinical trialist Professor Sir Martin Landray, will collaborate to develop new approaches to large randomised clinical trials.  Through the collaboration, the partners hope to enable better evidence-based treatments for common conditions, such as heart and… Read More

#News